Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrlecit in pediatric hemodialysis patients
NCT00223964Phase 4Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Jun 2003
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, double-blind trial of sodium ferric gluconate in iron deficiency anemia (IDA) (2 arms), sponsored by Watson Pharmaceuticals. Primary endpoint: Change in Hemoglobin at 2 weeks. Started Jun 2003; status: completed.
02
Drugs
sodium ferric gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT00223964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223964.